Abstract
Caring for patients with acute myocardial infarction (AMI) in a dedicated critical care unit was introduced in 1962 and over the next decade became widespread throughout North America and Europe. There was a significant reduction in mortality from between 30% and 35% to about 20% within 5-6 years of introducing the coronary care unit (CCU). As these results became available and more knowledge accrued of the mechanisms involved with sudden death and cardiac failure, it became the accepted norm for patients with AMI to be admitted to the CCU. However, due to the lack of distinguishing features of chest pain and the lack of diagnostic specificity of the electrocardiogram (ECG), it was often necessary to admit the patient to the CCU to subsequently exclude myocardial infarction. Initially the diagnostic enzymatic markers performed in the CCU consisted of serum glutamic oxaloacetic transaminase (SCOT), lactic dehydrogenase (LDH), and creatine kinase (CK), which were performed daily for 3 days for exclusion of infarction
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Roberts R. Enzymatic diagnosis of acute myocardial infarction. Chest 93:3S, 1988.
Roberts R. Diagnostic assessment of myocardial infarction based on lactate dehydrogenase and creatine kinase isoenzymes. Heart Lung 10:486, 1981.
Roe CR, Limbird LE, Wagner GS, Nerenberg ST. Combined isoenzyme analysis in the diagnosis of myocardial injury: Application of electrophoretic methods for the detection and the quantitation of the creatine phosphokinase MB isoenzyme. J Lab Clin Med 80:577, 1972.
Roberts R. Reperfusion and the plasma isoforms of creatine kinase isoenzymes: A clinical perspective. J Am Coll Cardiol 9:464, 1987.
Selker HP. Coronary care unit triage decision aids: How do we know when they work? Am J Med 87:491, 1989.
Lee TH, Weisberg MC, Brand DA, Rouan GW, Goldman L. Candidates for thrombolysis among emergency room patients with acute chest pain. Ann Intern Med 110:957, 1989.
Weingarten SR, Ermann B, Riedinger MS, Shah PK, Ellrodt G. Selecting the best triage rule tor patients hospitalized with chest pain. Am J Med 87:494, 1989.
Young MJ, McMahon LF, Stross JK. Prediction rules for patients with suspected myocardial infarction. Arch Intern Med 147:1219, 1987.
Stark ME, Vacek JL. The initial electrocardiogram during admission for myocardial infarction. Arch Intern Med 47:843, 1987.
Fesmire FM, Percy RF, Wears RL, MacMath TL. Risk stratification according to the initial electrocardiogram in patients with suspected acute myocardial infarction. Arch Intern Med 149:1294, 1989.
Roberts R. Thrombolysis and its sequelae: Calcium antagonists as potential adjunctive therapy. Circulation 80:IV93, 1989.
Brush JE, Brand DA, Acampora D, Chalmer B, Wackers FJ. Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction. N Engl J Med 312:1137, 1985.
Yusuf S, Pearson M, Sterry H. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. Eur Heart J 5:690, 1984.
Lee TH, Rouan GW, Weisberg MC, Brand DA, Cook EF, Acampora D, Goldman L. Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization. Ann Intern Med 106:181, 1987.
Lee TH, Juarez G, Cook EF, Weisberg MC, Rouan GW, Brand DA, Goldman L. Ruling out acute myocardial infarction. N Engl J Med 324:1239, 1991.
Puleo PR, Guadagno PA, Roberts R, Perryman MB. Sensitive, rapid assay of subforms of creatine kinase MB in plasma. Clin Chem 35:1452, 1989.
Puleo PR, Guadagno PA, Roberts R, Scheel MV, Marian AJ, Churchill D, Perryman MB. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation 82:759, 1990.
Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler SH, Hamburg RJ, Ali MN, Obermueller SD, Triana JT, Zimmerman JL, Perryman MB, Roberts R. Use of rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 331:561, 1994.
Delahunty TJ, Forback CC. Automated creatine kinase-MB estimation by immunoinhibition: A clinical evaluation. Clin Chem 26:568, 1980.
de Winter RJ, Koster RW, Sturk A, Sanders GT. Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 92:3401, 1995.
Adams JE, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 88:101, 1993.
Adams JE, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Davila-Roman VG, Bodar GS, Ladenson JH, and Jaffe AS. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 330:670, 1994.
Perryman MB, Strauss AW, Olson J, Roberts R. In vitro translation of canine mitochondrial creatine kinase from messenger RNA. Biochem Biophys Res Commun 110:967, 1983.
Perryman MB, Kerner SA, Bohlmeyer TJ, Roberts R. Isolation and sequence analysis of a full-length cDNA for human M creatine kinase. Biochem Biophys Res Commun 140:981, 1986.
Villarreal-Levy G, Ma TS, Kerner SA, Roberts R, Perryman MB. Human creatine kinase: Isolation and sequence analysis of cDNA clones for the B subunit, development of subunit specific probes and determination of gene copy number. Biochem Biophys Res Commun 144:1116, 1987.
Wevers RA, Delsing M, Klein-Gebbink JA, Soons JB. Post-synthetic changes in creatine kinase isoenzymes. Clin Chim Acta 86:323, 1978.
George S, Ishikawa Y, Perryman MB, Roberrs R. Purification and characterization of naturally occurring and in vitro induced multiple forms of MM creatine kinase. J Biol Chem 259:2667, 1984.
Billadello JJ, Fontanet HL, Strauss AW, Abendschein DR. Characterization of MB creatine kinase isoform conversion in vitro and in vivo in dogs. J Clin Invest 83:1637, 1989.
Hashimoto H, Abendschein DR, Strauss AW, Sobel BE. Early detection of myocardial infarction in conscious dogs by analysis of plasma MM creatine kinase isoforms. Circulation 71:363, 1985.
Jaffe AS, Serota H, Grace A, Sobel BE. Diagnostic-changes in plasma creatine kinase isoforms early after the onset of acute myocardial infarction. Circulation 74:105, 1986.
Wu AH, Gornet TG, Wu VH, Brockie RE, Nishikawa A. Early diagnosis of acute myocardial infarction by rapid analysis of creatine kinase isoenzyme-3 (CK-MM) subtypes. Clin Chem 33:358, 1987.
Grande P, Christiansen C, Pedersen A, Christensen MS. Optimal diagnosis in acute myocardial infarction. A cost effectiveness study. Circulation 61:723, 1980.
Klein MS, Shell WE, Sobel BE. Serum creatine phosphokinase (CPK) isoenzymes after intramuscular injections, surgery, and myocardial infarction. Experimental and clinical studies. Cardiovasc Res 7:412, 1973.
Apple FS, Rogers MA, Ivy JL. Early detection of skeletal muscle injury by assay of creatine kinase MM isoforms in serum after acute exercise. Clin Chem 34:1102, 1988.
Apple FS, Rogers MA, Ivy JL. Creatine kinase isoenzyme MM variants in skeletal muscle and plasma from marathon runners. Clin Chem 32:41, 1986.
Clarkson PM, Apple FS, Byrnes WC, McCormick KM, Triffletti P. Creatine kinase isoforms following isometric exercise. Muscle Nerve 10:41, 1987.
Annesley TM, Strongwater SL, Schnitzer TJ. MM subisoenzymes of creatine kinase as an index of disease activity in polymyositis. Clin Chem 31:402, 1985.
Henry PD, Roberts R, Sobel BE. Rapid separation of plasma creatine kinase isoenzymes by batch absorption with glass beads. Clin Chem 21:844, 1975.
Turi ZG, Rutherford JD, Roberts R, Muller JE, Jaffe AS, Rude RE, Parker C, Raabe DS, Stone PH, Hartwell TD, Lewis SE, Parkey RW, Gold HK, Robertson TL, Sobel BE, Willerson JT, Braunwald E, and the MILIS Study Group. Electrocardiographic, enzymatic and scintigraphic criteria of acute myocardial infarction as determined from study of 726 patients (a MILIS Study). Am J Cardiol 55:1463, 1985.
MILIS Study Group. National Heart, Lung, and Blood Institute Multicenter Investigation of the Limitation of Infarct Size (MILIS): Design and Methods of the Clinical Trial. An Investigation of Beta-Blockade and Hyaluronidase for Treatment of Acute Myocardial Infarction. Dallas, TX: American Heart Association Monograph 100, 1984.
Yasmineh WG, Ibrahim GA, Abbasnezhad MA, Awad EA. Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders. Clin Chem 24:1985, 1978.
Apple FS, Rogers MA, Sherman WM, Costill DL, Hagerman FC, Ivy JL. Profile of creatine kinase isoenzymes in skeletal muscles of marathon runners. Clin Chem 30:413, 1984.
Ohman EM, Sigmon KN, Califf RM. Is diagnostic certainty essential for the use of thrombolytic therapy during myocardial infarction in the 1990s? Circulation 82:1073, 1990.
Michael LH, Hunt JR, Weilbaecher D, Perryman MB, Roberts R, Lewis RM, Entman ML. Creatine kinase and phosphorylase in cardiac lymph: Coronary occlusion and reperfusion. Am J Physiol 17:H350, 1985.
Heyndrickx GR, Amano J, Kenna T, Fallon JT, Patrick TA, Manders WT, Rogers GG, Rosendorff C, Vatner SF. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol 6:1299, 1985.
Ishikawa Y, Saffitz JE, Mealman JE, Grace AM, Roberts R. Reversible myocardial ischemic injury is not associated with increased creatine kinase activites in plasma. Clin Chem 43:467, 1997.
Grenadier E, Keidar S, Kahana L, Alpan G, Marmor A, Palant A. The roles of serum myoglobin, total CPK, and CK-MB isoenzyme in the acute phase of myocardial infarction. Am Heart J 105:408, 1983.
Bhayana V, Henderson AR. Evaluation of cardio-REP for creatine kinase isoforms analaysis (abstr). Clin Chem 4l:S184, 1995.
Plebani M, Secchiero S, Altinier S, Lachin M, Sciacovelli L. Evaluation of a new automated system for CK-MB isoforms determination (abstr). Clin Chem 41:S174, 1995.
Snow JS, Cohen MB, Morrison J, Ward M, Sama AE, Ryan JG, Tria L, Syn T. CK-MB isoforms as a marker of myocadial infarction (abstr). J Investig Med 43:313, 1995.
Cannon CP, Walls RM. Editorial: Waiting for godot: Use of chemical markers in the emergency department evaluation of chest pain. J Emerg Med 13:533, 1995.
Roberts R, From R, Beaudreaux A, Zimmerman J, Meyer D, Wun C, Davis B, Smallings R, Habib G. Multi-center blinded trial utilizing multiple diagnostic markers to exclude myocardial infarction in patients presenting consecutively to the ER with chest pain (abstr). Circulation 94:1, 1996.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Kluwer Academic Publishers
About this chapter
Cite this chapter
Roberts, R. (1997). Early Diagnosis of Myocardial Infarction with MB-CK Subforms. In: Becker, R.C. (eds) Textbook of Coronary Thrombosis and Thrombolysis. Developments in Cardiovascular Medicine, vol 193. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-33754-8_32
Download citation
DOI: https://doi.org/10.1007/978-0-585-33754-8_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-9923-0
Online ISBN: 978-0-585-33754-8
eBook Packages: Springer Book Archive